What's New in Biliary Atresia?

Abstract

The main problem with biliary atresia (BA) is three-fold. Early diagnosis and timely therapy is mandatory in this rare and life-threatening disease. In as much as the aetiology of BA is unknown, all therapeutic attempts are still symptomatically orientated and finally, at the end-stage of the disease, the majority of the patients need organ replacement. Due to promising interdisciplinary cooperation and improved outcomes after liver transplantation, the overall survival rate of patients with BA increased remarkably during the last decades. Additionally, every effort was made in clinical and basic research to obtain a better understanding of the disease and its clinical course. Nevertheless, the nature of biliary atresia still remains unclear and therapeutic options are unsatisfactory. Numerous papers about BA have appeared, reflecting clinical and scientific activity. Considering recent publications and prospective activities, in the following we will summarise what is new in biliary atresia.

Résumé

La problématiqe de l'atrésie des voies biliaires est triple. Il s'agit d'établir un diagnostic précoce pour permettre une prise en charge thérapeutique optimale en raison du risque vital. L'étiologie de l'atrésie des voies biliaires étant inconnue, le traitement reste essentiellement symptomatique et la plupart des patients seront candidats à la transplantation. Grâce à une meilleure concertation pluridisciplinaire et aux progrès de la transplantation hépatique, le taux de survie des patient atteints d'atrésie des voies biliaires s'est nettement amélioré ces dernières annŽes. Par ailleurs, des avancées de la recherche clinique et fondamentale ont permis une meilleure connaissance de la maladie et de son évolution. Néanmoins, la nature de l'atrésie biliaire demeure peu claire et les options thérapeutiques ne sont pas satisfaisantes. En nous appuyant sur de nombreuses publications, témoignant de l'activité clinique et scientifique dans ce domaine, nous présentons une mise au point des nouveautés de l'atrésie des voies biliaires.

Resumen

El principal problema con la atresia biliar (AB) es triple: 1. el diagnóstico precoz y el tratamiento a tiempo son imprescindibles en esta enfermedad rara y amenazadora. 2. Al ser la etiología de la AB desconocida todos los intentos de tratamiento son todavía orientados sintomáticamente y finalmente 3. En fases finales de la enfermedad la mayoría de los pacientes requieren trasplante. Debido a la prometedora cooperación interdisciplinaria y al progresivamente mejor resultado tras el trasplante hepático la sobrevivencia global de los pacientes con AB ha aumentado considerablemente en la últimas décadas. Adicionalmente se siguen haciendo esfuerzos de investigación clínica y básica para mejor comprender la enfermedad y su curso clínico. Sin embargo, la naturaleza de la atresia biliar todavía es poco clara y las opciones terapeúticas no son satisfactorias. Numerosos artículos sobre la AB reflejan esta actividad clínica y científica. Considerando las publicaciones recientes y las actividades prospectivas resumimos el estado actual de esta enfermedad.

Zusammenfassung

Die Gallengangsatresie (BA) ist eine seltene Erkrankung, die oft zu spät diagnostiziert und nicht immer rechtzeitig behandelt wird. Zumal die Ätiologie der BA bis heute nicht bekannt ist, erfolgen alle therapeutischen Ansätze symptomorientiert. Trotz technisch erfolgreicher Portoenterostomie benötigen die meisten der betroffenen Patienten früher oder später eine Lebertransplantation (LTx). Dank vielversprechender interdisziplinärer Kooperation und deutlicher Verbesserung der Ergebnisse nach LTx ist die Lebenserwartung von Kindern mit BA erheblich angestiegen. Außerdem wurden große Fortschritte in der klinischen und auch der Grundlagenforschung gemacht. Das eigentliche Wesen der BA bleibt aber bis heute unklar und die Behandlungsoptionen sind weiterhin unbefriedigend. Jährlich erscheinen zahlreiche Veröffentlichungen zur BA und spiegeln die klinischen und wissenschaftlichen Aktivitäten wider. Unter Berücksichtigung dieser Publikationen sowie zukünftiger Aktivitäten werden wir im Folgenden zusammenfassen, was es Neues zur Gallengangatresie gibt.

Biliary atresia

Atrésie de voies biliaires

Atresia biliar

Gallengangsatresie

References

• 1 Ahmed A F, Ohtani H, Nio M, Funaki N, Sasaki H, Nagura H, Ohi R. Intrahepatic mast cell population correlates with clinical outcome in biliary atresia.  J Pediatr Surg. 2000;  35 1762-1765
• 2 Ahmed A F, Ohtani H, Nio M, Funaki N, Iwami D, Kumagai S, Sato E, Nagura H, Ohi R. In situ expression of fibrogenic growth factors and their receptors in biliary atresia: comparison between early and late stages.  J Pathol. 2000;  192 73-80
• 3 Ahmed A F, Nio M, Ohtani H, Nagura H, Ohi R. In situ CD 14 expression in biliary atresia: comparison between early and late stages.  J Pediatr Surg. 2001;  36 240-243
• 4 Ahmed A F, Nio M, Ohtani H, Nagura H, Ohi R. Clinical significance of c-kit expression in biliary atresia.  Pediatr Surg Int. 2001;  17 601-603
• 5 Azar G, Benek D, Lane B, Markowitz J, Daum F, Kahn E. Atypical morphogenic presentation of biliary atresia and value of serial liver biopsies.  J Pediatr Gastroenterol Nutr. 2002;  34 212-215
• 6 Balistreri W F, Grand R, Hoofnagle J H, Suchy F J, Ryckman F C, Perlmutter D H, Sokol R J. Biliary atresia: current concepts and research directions. Summary of a symposium.  Hepatology. 1996;  23 1682-1692
• 7 Carceller A, Blanchard H, Alvarez F, St-Vil D, Bensoussan A L, Di Lorenzo M. Past and future of biliary atresia.  J Pediatr Surg. 2000;  35 717-720
• 8 Chardot C, Carton M, Spire-Bendelac N, Le Pommelet C, Golmard J L, Auvert B. Prognosis of biliary atresia in the era of liver transplantation: French national study from 1986 to 1996.  Hepatology. 1999;  30 606-611
• 9 Chardot C, Carton M, Spire-Bendelac N, Le Pommelet C, Golmard J, Reding R, Auvert B. Is the Kasai operation still indicated in children older than 3 months diagnosed with biliary atresia?.  J Pediatr. 2001;  138 224-228
• 10 Czech-Schmidt G, Verhagen W, Szavay P, Leonhardt J, Petersen C. Immunological gap in the infectious animal model for biliary atresia.  J Surg Res. 2001;  101 62-67
• 11 Davenport M, Gonde C, Redkar R, Koukoulis G, Tredger M, Mieli-Vergani G, Portmann B, Howard E R. Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia.  J Pediatr Surg. 2001;  36 1017-1025
• 12 Dhawan A, Trivedi P, Cheeseman P, Baker A J, Howard E R, Mieli-Vergani G. Serum hyaluronic acid as an early prognostic marker in biliary atresia.  J Pediatr Surg. 2001;  36 443-446
• 13 Dillon P W, Owings E, Cilley R, Field D, Curnow A, Georgeson K. Immunosuppression as adjuvant therapy for biliary atresia.  J Pediatr Surg. 2001;  36 80-85
• 14 Hasegawa T, Kimura T, Sasaki T, Okada A. Plasma endothelin-1 level as a marker reflecting the severity of portal hypertension in biliary atresia.  J Pediatr Surg. 2001;  36 1609-1612
• 15 Hay S A, Soliman H E, Sherif H M, Abdelrahman A H, Kabesh A A, Hamza A F. Neonatal jaundice: the role of laparoscopy.  J Pediatr Surg. 2000;  35 1706-1709
• 16 Howard E R, MacLean G, Nio M, Donaldson N, Singer J, Ohi R. Survival patterns in biliary atresia and comparison of quality of life of long-term survivors in Japan and England.  J Pediatr Surg. 2001;  36 892-897
• 17 Iinuma Y, Narisawa R, Iwafuchi M, Uchiyama M, Naito M, Yagi M, Kanada S, Otaki M, Yamazaki S, Honma T, Motoyama H, Baba Y. The role of endoscopic retrograde cholangiopancreatography in infants with cholestasis.  J Pediatr Surg. 2000;  35 545-549
• 18 Ishitani M B. Biliary atresia and the Kasai portoenterostomy: Never say never?.  Liver Transpl. 2001;  7 831-832
• 19 Kelly D. The United Kingdom restricts surgery for biliary atresia.  J Pediatr Gastroenterol Nutr. 1999;  29 529
• 20 Kobayashi H, Narumi S, Tamatani T, Lane G J, Miyano T. Serum IFN-inducible protein-10: a new clinical prognostic predictor of hepatocyte death in biliary atresia.  J Pediatr Surg. 1999;  34 308-311
• 21 Kobayashi H, Horikoshi K, Yamataka A, Lane G J, Watanabe S, Futagawa S, Miyano T. α-Gluthathione-s-transferase as a new sensitive marker of hepatocellular damage in biliary atresia.  Pediatr Surg Int. 2000;  16 302-305
• 22 Kobayashi H, Horikoshi K, Yamatak A, Lane G J, Furuhata A, Sueyoshi N, Miyano T. Are stable postoperative biliary atresia patients really stable?.  Pediatr Surg Int. 2001;  17 104-107
• 23 Kotb M A, Kotb A, Sheba M F, El Koofy N M, El-Karaksy H M, Abdel-Kahlik M K, Abdalla A, El-Regal M E, Warda R, Mostafa H, Karjoo M, A-Kader H H. Evaluation of the triangular cord sign in the diagnosis of biliary atresia.  Pediatrics. 2001;  108 416-420
• 24 Lamireau T, Le Bail B, Boussarie L, Fabre M, Vergnes P, Bernard O, Gaitier F, Bioulac-Sage P, Rosenbaum J. Expression of collagens type I and IV, osteonectin and transforming growth factor bet-1 (TGFβ1) in biliary atresia and paucity of intrahepatic bile ducts during infancy.  J Hepatol. 1999;  31 248-255
• 25 Landing B H. Considerations of the pathogenesis of neonatal hepatitis, biliary atresia and choledochal cyst - the concept of infantile obstructive cholangiopathy.  Prog Pediatr Surg. 1974;  6 113-139
• 26 Lloyd D, Jones M, Dalzell M. Surgery for biliary atresia.  Lancet. 2000;  355 1099-1100
• 27 Lopez-Santamaria M, Gamez M, Murcia J, Diez-Pardo J, Diaz M, Leal N, Lobato R, Martinez L, Hierro L, Camarena C, De la Vega A, Frauca E, Jara P, Berrocal T, Prieto C, Cortes P, Tovar J. Long-term follow-up of patients with biliary atresia successfully treated with hepatic portoenterostomy. The importance of sequential treatment.  Pediatr Surg Int. 1998;  13 327-330
• 28 Low Y, Vijayan V, Tan C E. The prognostic value of ductal plate malformation and other histologic parameters in biliary atresia: animmunohistochemical study.  J Pediatr. 2001;  139 320-322
• 29 Matsuo S, Suita S, Kubota M, Shono K, Kamimura T, Kinugasa Y. Hazards of hepatic portocholecystostomy in biliary atresia.  Eur J Pediatr Surg. 2001;  11 19-23
• 30 Migliazza L, Lopez Santamaria M, Murcia J, Gamez M, Clavijo J, Camarena C, Hierro L, Frauca E, de la Vega A, Diaz M, Jara P, Tovar J A. Long-term survival expectancy after liver transplantation in children.  J Pediatr Surg. 2000;  35 5-7 7-8
• 31 Minnick K E, Kreisberg R, Dillon P W. Soluble ICAM-1 (sICAM-1) in biliary atresia and its relationship to disease activity.  J Surg Res. 1998;  76 53-56
• 32 Mowat A P. Biliary atresia into the 21st century: a historical perspective.  Hepatology. 1996;  23 1693-1695
• 33 Muraji T, Higashimoto Y. The improved outlook for biliary atresia with corticosteroid therapy.  J Pediatr Surg. 1997;  32 1103-1107
• 34 Murcia J, Vazquez J, Lopez S M, Gamez M, Hierro L, Camarena C, de la Vega A, Frauca E, Diaz M C, Jara P, Tovar J. Innovative techniques in pediatric liver transplantation: reduced-, split- and living-donor related liver transplantation.  Eur J Pediatr Surg. 1996;  6 152-154
• 35 Noujaim H M, Mayer D A, Buckles J AC, Beath S V, Kelly D A, McKiernan P J, Mirza D F, de Villede Goyet J. Techniques for and outcome of liver transplantation in neonates and infants weighing up to 5 kilograms.  J Pediatr Surg. 2002;  37 159-164
• 36 Ohhama Y, Shinkai M, Fujita S, Nishi T, Yamamoto H. Early prediction of long-term survival and the timing of liver transplantation after the Kasai operation.  J Pediatr Surg. 2000;  35 1031-1034
• 37 Okazaki T, Kobayashi H, Yamataka A, Lane G J, Miyano T. Long-term postsurgical outcome of biliary atresia.  J Pediatr Surg. 1999;  34 312-315
• 38 Otte J B, de Ville de Goyet J, Reding R, Van Obbergh L, Veyckemans F, Carlier M A, De Kock M, Clement de Clety S, Clapuyt P, Sokal E, Lerut J, Delbeke I, Dierick V, Janssen M, Rosati R, Libert F. Pediatric liver transplantation: from the full-size liver graft to reduced, split, and living related liver transplantation.  Pediatr Surg Int. 1998;  13 308-318
• 39 Park W H, Choi S O, Lee H J. The ultrasonographic “triangular cord sign” coupled with gallbladder images in the diagnostic prediction of biliary atresia from infantile intrahepatic cholestasis.  J Pediatr Surg. 1999;  34 1706-1710
• 40 Petersen C, Biermanns D, Kuske M, Schakel K, Meyer-Junghanel L, Mildenberger H. New aspects in a murine model for extrahepatic biliary atresia.  J Pediatr Surg. 1997;  32 1190-1195
• 41 Petersen C, Grasshoff S, Luciano L. Diversifying morphology of biliary atresia in an animal model.  J Hepatol. 1998;  28 603-607
• 42 Riepenhoff-Talty M, Schaekel K, Clark H F, Mueller W, Uhnoo I, Rossi T, Fisher J, Ogra P L. Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice.  Pediatr Res. 1993;  33 394-399
• 43 Rudolph J A, Balistreri W F. Optimal treatment of biliary atresia: “halfway” there!.  Hepatology. 1999;  30 808-810
• 44 Sathienkijakarnchi P, Chongrisawat V, Charoensapaya J, Tanprayoon T, Chandrakamol B, Suwangool P, Poovorwan Y. The relationship between procollagen-III-peptide and the severity of esophageal varices in children with biliary atresia after Kasai operation.  Pediatr Surg Int. 2002;  18 32-35
• 45 Schoen B T, Lee H, Sullivan K, Ricketts R R. The Kasai portoenterostomy: when is it too late?.  J Pediatr Surg. 2001;  36 97-99
• 46 Schreiber R A, Kleinman R E. Genetics, immunology, and biliary atresia: an opening or a diversion?.  J Pediatr Gastroenterol Nutr. 1993;  16 111-113
• 47 Schweizer P, Kirschner H, Schittenhelm C. Anatomy of the porta hepatis as a basis for extended hepatoporto-enterostomy for extrahepatic biliary atresia: a new surgical technique.  Eur J Pediatr Surg. 2001;  11 15-18
• 48 Senyuz O F, Yesildag E, Emir H, Tekant G, Bozkurt P, Sarimurat N, Soylet Y. Diagnostic laparoscopy in prolonged jaundice.  J Pediatr Surg. 2001;  36 463-465
• 49 Tan C E, Driver M, Howard E R, Moscoso G J. Extrahepatic biliary atresia: a first-trimester event? Clues from light microscopy and immunohistochemistry.  J Pediatr Surg. 1994;  29 808-814
• 50 Urushihara N, Iwagaki H, Yagi T, Kohka H, Kobashi K, Morimoto Y, Yoshino T, Tanimoto T, Kurimoto M, Tanaka N. Elevation of serum interleukin-18 levels and activation of Kupffer cells in biliary atresia.  J Pediatr Surg. 2000;  35 446-449
• 51 Volpert D, White F, Finegold M J, Molleston J, Debaun M, Perlmutter D H. Outcome of early hepatic portoenterostomy for biliary atresia.  J Pediatr Gastroenterol Nutr. 2001;  32 265-269
• 52 Wu E T, Chen H L, Ni Y H, Lee P I, Hsu H Y, Lai H S, Chang M H. Bacterial cholangitis in patients with biliary atresia: impact on short outcome.  Pediatr Surg Int. 2001;  17 390-395